Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72162-1516

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 72162-1516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621516)

Label for olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets 40 mg / 10 mg / 12.5 mg, film coated oral tablets. The label indicates a package of 90 tablets, labeled by Bryant Ranch Prepack and manufactured by Par Pharmaceutical. Directions for storage and child safety warnings are included on the label.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure of olmesartan medoxomil, part of the combination drug olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide. The structure shows detailed molecular bonds and functional groups characteristic of olmesartan medoxomil.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure diagram representing the active ingredients in olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide combination drug. The image shows molecular structures including rings and functional groups relevant to these compounds.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure of olmesartan medoxomil, showing atoms and bonds including sulfonamide, benzene ring with chlorine, and other groups characteristic to the molecule.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

Line graph depicting changes over time with multiple data series representing different drug combinations including olmesartan medoxomil 40 mg alone, and combinations with hydrochlorothiazide (HCTZ) 10 mg, 25 mg, and olmesartan medoxomil 40 mg/amlodipine besylate 10 mg/hydrochlorothiazide 25 mg. The y-axis ranges approximately from 55 to 100, showing trends below baseline values for each series.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing systolic blood pressure (mmHg) on the y-axis and hours post dose on the x-axis. It compares blood pressure changes over 24 hours for different treatment groups, including Baseline, AML 10/HCTZ25, OM40/AML10, OM40/HCTZ25, and OM40/AML10/HCTZ25, with multiple lines representing each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.